AGC Biologics to acquire cell and gene therapy manufacturing facility in Longmont, Colorado
CDMO AGC Biologics will purchase a cell and gene therapy commercial manufacturing facility in Longmont, Colorado, from Novartis Gene Therapies.
Archives for July 5, 2021
Sartorius acquires majority stake in CellGenix
Sartorius is strengthening its product portfolio for cell and gene therapies with the acquisition of a majority stake in German reagent manufacturer CellGenix.
Viralgen expands AAV vector manufacturing in Spain
Bayer owned CDMO, Viralgen, has expanded its AAV vector manufacturing capabilities in San Sebastian, in the Basque region of Spain, with the opening last week of a new site.
EMA backs active substance scale-up at Janssen’s COVID-19 vaccine site in the Netherlands
The committee for human medicines (CHMP) of the European Medicines Agency (EMA) has approved a scale-up of the active substance manufacturing process at a Janssen Biologics BV site in the Netherlands.